Cite
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.
MLA
Ueno, Hideki, et al. “Phase I/II Study of Nab-Paclitaxel plus Gemcitabine for Chemotherapy-Naive Japanese Patients with Metastatic Pancreatic Cancer.” Cancer Chemotherapy & Pharmacology, vol. 77, no. 3, Mar. 2016, pp. 595–603. EBSCOhost, https://doi.org/10.1007/s00280-016-2972-3.
APA
Ueno, H., Ikeda, M., Ueno, M., Mizuno, N., Ioka, T., Omuro, Y., Nakajima, T., Furuse, J., & Nakajima, T. E. (2016). Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Chemotherapy & Pharmacology, 77(3), 595–603. https://doi.org/10.1007/s00280-016-2972-3
Chicago
Ueno, Hideki, Masafumi Ikeda, Makoto Ueno, Nobumasa Mizuno, Tatsuya Ioka, Yasushi Omuro, Takako Nakajima, Junji Furuse, and Takako Eguchi Nakajima. 2016. “Phase I/II Study of Nab-Paclitaxel plus Gemcitabine for Chemotherapy-Naive Japanese Patients with Metastatic Pancreatic Cancer.” Cancer Chemotherapy & Pharmacology 77 (3): 595–603. doi:10.1007/s00280-016-2972-3.